Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered

See also
Status	Clinical Trial	Phase
Completed	`NCT01461993` - A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17	Phase 2
Completed	`NCT01461980` - A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age	Phase 2
Not yet recruiting	`NCT05993325` - Immunogenicity and Safety of AdCLD-CoV19-1 OMI as a Booster: A COVID-19 Preventive Vaccine in Healthy Volunteers	Phase 3
Completed	`NCT02692976` - Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients	Phase 2
Active, not recruiting	`NCT05284097` - Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study	Phase 2
Recruiting	`NCT06259487` - Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.	N/A
Active, not recruiting	`NCT05576623` - Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine	Phase 1/Phase 2
Completed	`NCT03294551` - HPV Centralized R/R RCT #2 - New York State	N/A
Not yet recruiting	`NCT06437834` - Increasing Men's Engagement in Preventive Healthcare Through an Enhanced Cocoon Vaccination Strategy	N/A
Completed	`NCT03666026` - Patient Portal - Flu Reminder Recall	N/A
Recruiting	`NCT05586178` - Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake	N/A
Recruiting	`NCT05586165` - Effects of Prompt to Bundle COVID-19 Booster and Flu Shot	N/A
Recruiting	`NCT05586204` - Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up	N/A
Completed	`NCT03294473` - Centralized Reminder Recall - Flu RCT2	N/A
Completed	`NCT05593042` - Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile	Phase 2
Completed	`NCT04651790` - Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults	Phase 3
Completed	`NCT01697007` - A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique	Phase 2
Completed	`NCT03548337` - Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India	Phase 4
Completed	`NCT02609035` - Immunization Services Model for Adult Rate Improvement	N/A
Active, not recruiting	`NCT05032976` - Korea Comirnaty Post-marketing Surveillance

NCT number	NCT00688870
Study type	Interventional
Source	Wyeth is now a wholly owned subsidiary of Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	June 5, 2008
Completion date	January 13, 2010

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms